A citation-based method for searching scientific literature

Kasper B Hansen, Kevin K Ogden, Stephen F Traynelis. J Neurosci 2012
Times Cited: 76







List of co-cited articles
1230 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glutamate receptor ion channels: structure, regulation, and function.
Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine. Pharmacol Rev 2010
77

Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
Ezio Bettini, Anna Sava, Cristiana Griffante, Corrado Carignani, Alberto Buson, Anna Maria Capelli, Michele Negri, Filippo Andreetta, Sergio A Senar-Sancho, Lorena Guiral,[...]. J Pharmacol Exp Ther 2010
100
59

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
Pierre Paoletti, Camilla Bellone, Qiang Zhou. Nat Rev Neurosci 2013
50


A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.
Praseeda Mullasseril, Kasper B Hansen, Katie M Vance, Kevin K Ogden, Hongjie Yuan, Natalie L Kurtkaya, Rose Santangelo, Anna G Orr, Phuong Le, Kimberly M Vellano,[...]. Nat Commun 2010
117
42

NMDA receptor structures reveal subunit arrangement and pore architecture.
Chia-Hsueh Lee, Wei Lü, Jennifer Carlisle Michel, April Goehring, Juan Du, Xianqiang Song, Eric Gouaux. Nature 2014
312
38


Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
Erkan Karakas, Noriko Simorowski, Hiro Furukawa. Nature 2011
231
35

Subunit arrangement and function in NMDA receptors.
Hiroyasu Furukawa, Satinder K Singh, Romina Mancusso, Eric Gouaux. Nature 2005
525
35

Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
Kasper B Hansen, Kevin K Ogden, Hongjie Yuan, Stephen F Traynelis. Neuron 2014
184
34

TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.
S Edman, S McKay, L J Macdonald, M Samadi, M R Livesey, G E Hardingham, D J A Wyllie. Neuropharmacology 2012
50
50

Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
S Vicini, J F Wang, J H Li, W J Zhu, Y H Wang, J H Luo, B B Wolfe, D R Grayson. J Neurophysiol 1998
521
30


Mechanism of differential control of NMDA receptor activity by NR2 subunits.
Marc Gielen, Beth Siegler Retchless, Laetitia Mony, Jon W Johnson, Pierre Paoletti. Nature 2009
229
28

Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
Timothy M Acker, Hongjie Yuan, Kasper B Hansen, Katie M Vance, Kevin K Ogden, Henrik S Jensen, Pieter B Burger, Praseeda Mullasseril, James P Snyder, Dennis C Liotta,[...]. Mol Pharmacol 2011
70
31

Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
Hongjie Yuan, Kasper B Hansen, Katie M Vance, Kevin K Ogden, Stephen F Traynelis. J Neurosci 2009
154
28

Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
David H Hackos, Patrick J Lupardus, Teddy Grand, Yelin Chen, Tzu-Ming Wang, Paul Reynen, Amy Gustafson, Heidi J A Wallweber, Matthew Volgraf, Benjamin D Sellers,[...]. Neuron 2016
108
28


A novel family of negative and positive allosteric modulators of NMDA receptors.
Blaise Mathias Costa, Mark W Irvine, Guangyu Fang, Richard J Eaves, Marie Belen Mayo-Martin, Donald A Skifter, David E Jane, Daniel T Monaghan. J Pharmacol Exp Ther 2010
69
30



Triheteromeric NMDA receptors at hippocampal synapses.
Kenneth R Tovar, Matthew J McGinley, Gary L Westbrook. J Neurosci 2013
135
26

Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
Christopher J Hatton, Pierre Paoletti. Neuron 2005
186
25

Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
Feng Yi, Tung-Chung Mou, Katherine N Dorsett, Robert A Volkmann, Frank S Menniti, Stephen R Sprang, Kasper B Hansen. Neuron 2016
57
33

Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
Cara A Mosley, Timothy M Acker, Kasper B Hansen, Praseeda Mullasseril, Karen T Andersen, Phuong Le, Kimberly M Vellano, Hans Bräuner-Osborne, Dennis C Liotta, Stephen F Traynelis. J Med Chem 2010
64
28

Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.
G Fischer, V Mutel, G Trube, P Malherbe, J N Kew, E Mohacsi, M P Heitz, J A Kemp. J Pharmacol Exp Ther 1997
384
22

X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor.
Alexander I Sobolevsky, Michael P Rosconi, Eric Gouaux. Nature 2009
719
22


Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
Kevin Erreger, Matthew T Geballe, Anders Kristensen, Philip E Chen, Kasper B Hansen, C Justin Lee, Hongjie Yuan, Phuong Le, Polina N Lyuboslavsky, Nicola Micale,[...]. Mol Pharmacol 2007
118
21

Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines.
Laetitia Mony, Shujia Zhu, Stéphanie Carvalho, Pierre Paoletti. EMBO J 2011
108
21



Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
Alpa Khatri, Pieter B Burger, Sharon A Swanger, Kasper B Hansen, Sommer Zimmerman, Erkan Karakas, Dennis C Liotta, Hiro Furukawa, James P Snyder, Stephen F Traynelis. Mol Pharmacol 2014
52
30

New advances in NMDA receptor pharmacology.
Kevin K Ogden, Stephen F Traynelis. Trends Pharmacol Sci 2011
139
19


Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.
Kevin Erreger, Shashank M Dravid, Tue G Banke, David J A Wyllie, Stephen F Traynelis. J Physiol 2005
318
19




Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
Shujia Zhu, Pierre Paoletti. Curr Opin Pharmacol 2015
102
18

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition.
Yves P Auberson, Hans Allgeier, Serge Bischoff, Kurt Lingenhoehl, Robert Moretti, Markus Schmutz. Bioorg Med Chem Lett 2002
177
17

Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.
Daniel T Monaghan, Mark W Irvine, Blaise Mathias Costa, Guangyu Fang, David E Jane. Neurochem Int 2012
65
20

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
Laetitia Mony, James N C Kew, Martin J Gunthorpe, Pierre Paoletti. Br J Pharmacol 2009
272
17


Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition.
Marc Gielen, Anne Le Goff, David Stroebel, Jon W Johnson, Jacques Neyton, Pierre Paoletti. Neuron 2008
94
17

Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo.
John A Gray, Yun Shi, Hiroshi Usui, Matthew J During, Kenji Sakimura, Roger A Nicoll. Neuron 2011
192
17

GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
Katie M Vance, Kasper B Hansen, Stephen F Traynelis. J Physiol 2012
39
33

High-affinity zinc inhibition of NMDA NR1-NR2A receptors.
P Paoletti, P Ascher, J Neyton. J Neurosci 1997
472
17

Diversity in NMDA receptor composition: many regulators, many consequences.
Antonio Sanz-Clemente, Roger A Nicoll, Katherine W Roche. Neuroscientist 2013
240
17

Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.
Matthew Volgraf, Benjamin D Sellers, Yu Jiang, Guosheng Wu, Cuong Q Ly, Elisia Villemure, Richard M Pastor, Po-wai Yuen, Aijun Lu, Xifeng Luo,[...]. J Med Chem 2016
59
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.